Heart Test Laboratories, Inc., a medical technology company, has formally requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-1 to 4:00 P.M. Eastern Time on March 13, 2024. The request, filed on March 12, 2024, aims for the registration to be effective as soon as possible or at a time thereafter as determined by the company's counsel. This step is part of the process for Heart Test Laboratories to become a publicly-traded company, allowing it to issue stocks to the public. The company has indicated that its counsel, Foley Shechter Ablovatskiy LLP, should be notified by phone upon the registration statement's effectiveness.

Heart Test Laboratories, Inc., a medical technology company, has formally requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-1 to 4:00 P.M. Eastern Time on March 13, 2024. The request, filed on March 12, 2024, aims for the registration to be effective as soon as possible or at a time thereafter as determined by the company's counsel. This step is part of the process for Heart Test Laboratories to become a publicly-traded company, allowing it to issue stocks to the public. The company has indicated that its counsel, Foley Shechter Ablovatskiy LLP, should be notified by phone upon the registration statement's effectiveness.